Citation 122509

HIZI,A: TAL,R: SHAHARABANY,M: CURRENS,MJ: BOYD,MR: HUGHES,SH: MC MAHON,JB:. (1993). SPECIFIC INHIBITION OF THE REVERSE TRANSCRIPTASE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND THE CHIMERIC ENZYMES OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 BY NONNUCLEOSIDE INHIBITORS.. 37(5)

Citation Details

Title	SPECIFIC INHIBITION OF THE REVERSE TRANSCRIPTASE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND THE CHIMERIC ENZYMES OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 BY NONNUCLEOSIDE INHIBITORS.
Authors	HIZI,A: TAL,R: SHAHARABANY,M: CURRENS,MJ: BOYD,MR: HUGHES,SH: MC MAHON,JB:
Year	1993
Volume	37
Issue	5

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	ACTIVE
2	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	INACTIVE
3	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	ACTIVE
4	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	INACTIVE
5	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	INACTIVE
6	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	INACTIVE
7	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	WEAK ACTIVITY
8	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	ACTIVE
9	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	INACTIVE
10	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	ACTIVE
11	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A	ACTIVE

Citation 122509

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1